Skip to main content

Effect of Soy Isoflavone Supplement on Poorly Controlled Asthma

academics

 

Clinical research courses

A new study says Soy supplements does not improve lung function for patients with asthma. This study is contrary to previous findings suggesting a link between soy intake and decreased asthma severity.

Indian-American researcher Ravi Kalhan, associate professor in medicine-pulmonary and preventive medicine at Feinberg also involved in  the study.

Lewis Smith, professor of medicine at Northwestern University Feinberg School of Medicine.
said "You are what you eat, but that's a whole constellation of foods, not just a single food or a single component of a food. Instead of focusing on supplements, we should be taking a more holistic approach." "We found that the supplement, though able to increase blood levels of the key soy isoflavone genistein, did not improve lung function, symptoms or measures of inflammation in these individuals," Smith said. He said "This study highlights why it is so important to perform well-designed, placebo-controlled studies when associations are reported between specific nutrients and disease outcomes,"

The study explored the effects of soy in 386 adults and children aged 12 or older with poorly controlled asthma. All were taking medicine to treat their asthma but none were consuming soy.
In the randomized study, half of the participants took a soy isoflavone supplement twice daily for six months, and the other half took a placebo.

The study shows in the Journal of the American Medical Association (JAMA).


<< Pharma News

Subscribe to PharmaTutor News Alerts by Email >>